Radiotherapy Market Size, Share, Trends, Analysis and Forecasts To 2022
Global Radiotherapy Market is accounted for $ 6.5 billion in 2015 and is expected to reach $ 10.2 billion by 2022 growing at a CAGR of 6.6 % during the forecast period. Rising number of cancer patients, technological advancements and increasing aging population are some of the key factors fueling the market growth. However, lack of sufficient infrastructure and healthcare costs are expected to hinder the market.
Download Sample Report @ https:// marketreportscenter. com / request-sample / 387627
Technologies such as External beam radiotherapy and internal beam radiotherapy are anticipated to witness highest growth owing to increased pool of cancer patients. North America commanded the largest market share as it is constantly inclined to the newer technologies when compared to slowmoving markets such as Europe. Rising incidence of cancer and unmet healthcare needs in APAC provides ample of opportunities for the players in the market over the foreseeable future.
Some of the key players in the market include Siemens Healthcare, GE Healthcare, Nordion, Inc., IBA Group, Angiodynamics Inc, Ion Beam Applications SA, Protom International Inc, IsoRay Medical, Inc., Coviden Plc, Varian Medical Systems Inc, Accuray Inc, Mevion Medical Systems, Inc, C. R. BARD Inc, CIVCO Medical Solutions, Mitsubishi Electric Corporation, Brainlab AG, RaySearch Laboratories AB, Elekta AB and Nanobiotix.
Equipments Covered: Linear Accelerators Treatment Planning Systems Radiation Therapy Simulators
Technologies Covered: Internal radiation therapy High Dose Rate Radiotherapy Low-Dose Rate Radiotherapy Systemic radiation therapy External Beam Radiation Therapy Stereotactic body radiation therapy Intensity-modulated radiation therapy( IMRT) 3D-Conformal Radiotherapy( 3D-CRT) Tomotherapy Volumetric Modulated ARC Therapy Image-guided radiation therapy( IGRT) Proton Beam therapy Stereotactic radiosurgery